Nektar Therapeutics | Los Gastos De Explotación





Los Gastos De Explotación Cambio Fecha
Agios Pharmaceuticals USD 129.75M 9.76M 2025-09
ALKERMES USD 1.73B 1.44B 2025-09
Alterity Therapeutics Limited AUD 7.78M 3M 2023-06
Amgen USD 5.9B 773M 2025-12
Baxter International USD 2.63B 95.8M 2025-09
BioCryst Pharmaceuticals USD -387.89M 33.7M 2025-09
Biogen USD 1.88B 81.4M 2025-09
Bristol-Myers Squibb USD 8.3B 10.25B 2025-12
Cara Therapeutics USD 4.96M 2.38M 2025-03
Cipla INR 60.98B 1.06B 2025-12
Dr.Reddys Laboratories INR 73.6B 1.79B 2025-12
Eisai JPY 199.9B 16.22B 2025-12
Eli Lilly USD 10.31B 1.09B 2025-12
Esperion Therapeutics USD 67.66M 3.6M 2024-09
Exelixis USD 341.4M 13.29M 2025-09
Gilead Sciences USD 4.26B 95M 2025-09
GlaxoSmithKline GBP 7.18B 1.42B 2025-12
Grifols EUR 1.77B 22.04M 2025-09
Halozyme Therapeutics USD 136.34M 13.06M 2025-09
Incyte USD 1.12B 3.53B 2025-12
Ionis Pharmaceuticals USD 316.9M 4.69M 2025-09
Ironwood Pharmaceuticals USD 57.33M 8.63M 2024-12
Karyopharm Therapeutics USD 61.82M 3.24M 2024-12
MacroGenics USD 67M 8M 2025-09
Merck USD 10.16B 558M 2025-12
Nektar Therapeutics USD 85.09M 109.3M 2025-09
Neurocrine Biosciences USD 555.6M 13.7M 2025-09
Novartis USD 9.86B 115M 2025-09
Pfizer USD 12.91B 79.89B 2025-12
Roche Holding CHF 21.01B 10.84B 2025-12
Sarepta Therapeutics USD 462.23M 33.28M 2025-09
Takeda JPY 1.02T 400.98B 2025-12
Teva Pharmaceutical Industries USD 4.22B 812M 2025-12
Xencor USD 68.52M 8.26M 2025-09


Nektar Therapeutics Los Gastos De Explotación - Los valores actuales, los datos históricos, las previsiones, estadísticas, gráficas y calendario económico - Feb 2026.